Targeting Neuroinflammation to Treat Alzheimer’s Disease
2017 · CNS Drugs · 224 citations
https://doi.org/10.1007/s40263-017-0483-3
K
Kelly Ceyzériat
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
2.0K
Citations
17
h-index
21
i10-index
Kelly Ceyzériat is an academic researcher from University of Geneva. The author has contributed to research in topics: Alzheimer's disease research and treatments & Neuroinflammation and Neurodegeneration Mechanisms & Tryptophan and brain disorders. The author has an h-index of 17, co-authored 48 publications.
ORCID: 0000-0001-5103-6722Papers by this author
worksTranslocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases
2023 · Nature Communications · 158 citations
https://doi.org/10.1038/s41467-023-40937-z
Dopaminergic dysfunction in the 3xTg-AD mice model of Alzheimer’s disease
2021 · Scientific Reports · 52 citations
https://doi.org/10.1038/s41598-021-99025-1
Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease
2024 · Neurobiology of Disease · 16 citations
https://doi.org/10.1016/j.nbd.2024.106623
Low-dose brain irradiation normalizes TSPO and CLUSTERIN levels and promotes the non-amyloidogenic pathway in pre-symptomatic TgF344-AD rats
2022 · Journal of Neuroinflammation · 15 citations
https://doi.org/10.1186/s12974-022-02673-x
Reactive astrocytes mediate TSPO overexpression in response to sustained CNTF exposure in the rat striatum
2023 · Molecular Brain · 14 citations
https://doi.org/10.1186/s13041-023-01041-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat